Aurélie Rossin

1.0k total citations
21 papers, 846 citations indexed

About

Aurélie Rossin is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Aurélie Rossin has authored 21 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cell Biology. Recurrent topics in Aurélie Rossin's work include Cell death mechanisms and regulation (9 papers), Retinoids in leukemia and cellular processes (9 papers) and Estrogen and related hormone effects (5 papers). Aurélie Rossin is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Retinoids in leukemia and cellular processes (9 papers) and Estrogen and related hormone effects (5 papers). Aurélie Rossin collaborates with scholars based in France, Italy and Spain. Aurélie Rossin's co-authors include Hinrich Gronemeyer, Anne‐Odile Hueber, Lucia Altucci, Christine Chomienne, Wolfgang Raffelsberger, Armin Reitmair, Fadi Abdel‐Sater, Mathieu Derouet, Jérôme Durivault and Angela Nebbioso and has published in prestigious journals such as Nature Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

Aurélie Rossin

21 papers receiving 831 citations

Peers

Aurélie Rossin

IMMUN

ONCOL

HEMAT

Angelika Rosenauer Canada

Hisato Gunji United States

Elena Cavadini Italy

Federica Brugnoli Italy

Stephanie Darmanin Japan

Kewen Zhao China

Federica Falà Italy

A. Marotta Canada

Leonie Gibson Australia

R Lotan United States

Angelika Rosenauer Canada

Aurélie Rossin

654 ×0.9

135 ×0.6

IMMUN

47 ×0.3

57 ×0.4

ONCOL

219 ×1.8

HEMAT

Citations per year, relative to Aurélie Rossin Aurélie Rossin (= 1×) peers Angelika Rosenauer

Countries citing papers authored by Aurélie Rossin

Since Specialization

Citations

This map shows the geographic impact of Aurélie Rossin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Rossin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Rossin more than expected).

Fields of papers citing papers by Aurélie Rossin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Rossin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Rossin. The network helps show where Aurélie Rossin may publish in the future.

Co-authorship network of co-authors of Aurélie Rossin

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Rossin. A scholar is included among the top collaborators of Aurélie Rossin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Rossin. Aurélie Rossin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González, Raúl, María Hernández, Kalina Ranguelova, et al.. (2020). Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer. Redox Biology. 34. 101528–101528. 16 indexed citations

Rossin, Aurélie, et al.. (2019). TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity. Cancers. 11(5). 639–639. 66 indexed citations

Laurent, G, Stéphane Audebert, Aurélie Rossin, et al.. (2018). Cell polarity and adherens junction formation inhibit epithelial Fas cell death receptor signaling. The Journal of Cell Biology. 217(11). 3839–3852. 17 indexed citations

Rossin, Aurélie, et al.. (2017). The Btk-dependent PIP5K1γ lipid kinase activation by Fas counteracts FasL-induced cell death. APOPTOSIS. 22(11). 1344–1352. 5 indexed citations

Rossin, Aurélie & Anne‐Odile Hueber. (2017). Detection of S-Acylated CD95 by Acyl-Biotin Exchange. Methods in molecular biology. 1557. 189–198. 1 indexed citations

Rossin, Aurélie, et al.. (2015). Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside. Immunobiology. 220(12). 1343–1350. 13 indexed citations

Rossin, Aurélie, et al.. (2014). Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability. Cell Death and Differentiation. 22(4). 643–653. 66 indexed citations

Guardiola-Serrano, Francisca, Aurélie Rossin, Nathalie Cahuzac, et al.. (2010). Palmitoylation of human FasL modulates its cell death-inducing function. Cell Death and Disease. 1(10). e88–e88. 40 indexed citations

Rossin, Aurélie, et al.. (2010). Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Experimental Cell Research. 316(9). 1513–1522. 18 indexed citations

10.

Shankaranarayanan, Pattabhiraman, Aurélie Rossin, Harshal Khanwalkar, et al.. (2009). Growth Factor-Antagonized Rexinoid Apoptosis Involves Permissive PPARγ/RXR Heterodimers to Activate the Intrinsic Death Pathway by NO. Cancer Cell. 16(3). 220–231. 30 indexed citations

11.

Maisse, Carine, Aurélie Rossin, Nathalie Cahuzac, et al.. (2008). Lipid raft localization and palmitoylation: Identification of two requirements for cell death induction by the tumor suppressors UNC5H. Experimental Cell Research. 314(14). 2544–2552. 16 indexed citations

12.

Rossin, Aurélie, Fadi Abdel‐Sater, Krittalak Chakrabandhu, et al.. (2006). Requirement for Daxx in mature T-cell proliferation and activation. Cell Death and Differentiation. 14(4). 795–806. 11 indexed citations

13.

Yin, Weihong, Aurélie Rossin, John L. Clifford, & Hinrich Gronemeyer. (2006). Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene. 25(26). 3735–3744. 30 indexed citations

14.

Altucci, Lucia, Aurélie Rossin, Angela Nebbioso, et al.. (2005). Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of Acute Myeloid Leukemia by Protein Kinase A–Mediated Desubordination of Retinoid X Receptor. Cancer Research. 65(19). 8754–8765. 89 indexed citations

15.

Ivanova, Diana, Aurélie Rossin, Hinrich Gronemeyer, et al.. (2004). Structure–activity relationships of methylene or terminal side chain modified retinoids on the differentiation and cell death signaling in NB4 promyelocytic leukemia cells. Bioorganic & Medicinal Chemistry Letters. 14(16). 4257–4261. 3 indexed citations

16.

Álvarez, Rosana, Sabrina Kammerer, Aurélie Rossin, et al.. (2004). 9-cis-Retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorganic & Medicinal Chemistry Letters. 14(24). 6117–6122. 9 indexed citations

17.

Ivanova, Diana, C. Gaudon, Aurélie Rossin, William Bourguet, & Hinrich Gronemeyer. (2002). RAR–RXR Selectivity and Biological Activity of New Retinoic Acid Analogues with Heterocyclic or Polycyclic Aromatic Systems. Bioorganic & Medicinal Chemistry. 10(7). 2099–2102. 8 indexed citations

18.

Guidez, Fabien, Lucia Altucci, Ke Xu, et al.. (2001). Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement.. Blood. 98(11). 3 indexed citations

19.

Altucci, Lucia, Aurélie Rossin, Wolfgang Raffelsberger, et al.. (2001). Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nature Medicine. 7(6). 680–686. 288 indexed citations

20.

Benoît, G, Maria Flexor, Françoise Besançon, et al.. (2001). Autonomous Rexinoid Death Signaling Is Suppressed by Converging Signaling Pathways in Immature Leukemia Cells. Molecular Endocrinology. 15(7). 1154–1169. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact